Suppr超能文献

胰头十二指肠腺癌孤立局部和转移性复发的切除术。

Resection of isolated local and metastatic recurrence in periampullary adenocarcinoma.

机构信息

Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

HPB (Oxford). 2014 Mar;16(3):197-203. doi: 10.1111/hpb.12119. Epub 2013 Apr 22.

Abstract

BACKGROUND

The majority of patients with periampullary cancer develop local or metastatic recurrence despite successful negative margin resection. Unfortunately, there are no established therapeutic strategies for managing these patients. The literature on the surgical resection of recurrent disease is limited.

METHODS

This is a retrospective study evaluating patients who underwent reoperative resection of recurrent periampullary cancer at a single institution between 1990 and 2011. Perioperative outcomes were compared with those of the original primary resections for patients with local recurrence. Kaplan-Meier curves were used to evaluate survival.

RESULTS

Twenty-two patients underwent reoperative resection following the successful primary resection of periampullary cancers. Median survival from the time of reoperation was 28.1 months. A greater survival benefit was seen in patients undergoing reoperative resection with >15 months between the primary resection and recurrence (40.6 months versus 8.2 months; P < 0.05). Complication rates were lower after reoperative resection compared with the primary resection (20% versus 70%). Perioperative characteristics including operative time, estimated blood loss and hospital stay were similar in both the primary and reoperation procedures.

CONCLUSIONS

Surgical resection of periampullary cancer recurrence is feasible, safe and may offer survival benefits in comparison with alternative treatment modalities. Reoperative resection should be considered, especially in patients in whom the time to recurrence is lengthy.

摘要

背景

尽管成功进行了阴性切缘切除,但大多数壶腹周围癌患者仍会出现局部或远处转移复发。遗憾的是,目前尚无针对这些患者的既定治疗策略。有关复发性疾病的外科切除的文献有限。

方法

这是一项回顾性研究,评估了 1990 年至 2011 年间在一家机构接受复发性壶腹周围癌再次手术切除的患者。将局部复发患者的围手术期结局与原始初次手术切除进行了比较。使用 Kaplan-Meier 曲线评估生存情况。

结果

22 例患者在成功进行壶腹周围癌初次切除后接受了再次手术切除。自再次手术时起的中位生存时间为 28.1 个月。在初次切除与复发之间间隔>15 个月的患者中,再次手术切除的生存获益更大(40.6 个月与 8.2 个月;P<0.05)。与初次切除术相比,再次手术切除后的并发症发生率更低(20%比 70%)。初次手术和再次手术的围手术期特征(包括手术时间、估计失血量和住院时间)相似。

结论

与其他治疗方式相比,手术切除壶腹周围癌复发是可行、安全的,并且可能带来生存获益。应考虑再次手术切除,特别是在复发时间较长的患者中。

相似文献

6
Reoperative surgery for periampullary adenocarcinoma.壶腹周围腺癌的再次手术
Arch Surg. 1991 Oct;126(10):1205-10; discussion 1210-2. doi: 10.1001/archsurg.1991.01410340043007.
9
Periampullary adenocarcinoma: analysis of 5-year survivors.壶腹周围腺癌:5年生存者分析
Ann Surg. 1998 Jun;227(6):821-31. doi: 10.1097/00000658-199806000-00005.

引用本文的文献

8
Surgery for Recurrent Pancreatic Cancer: Is It Effective?复发性胰腺癌手术:是否有效?
Cancers (Basel). 2019 Jul 16;11(7):991. doi: 10.3390/cancers11070991.

本文引用的文献

2
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
5
FOLFIRINOX: a great leap forward, but for whom?FOLFIRINOX方案:向前的一大步,但对谁而言?
J Clin Oncol. 2012 Jan 1;30(1):114-5; author reply 114. doi: 10.1200/JCO.2011.39.4056. Epub 2011 Nov 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验